Kennedy Capital Management, Inc. Cti Biopharma Corp Transaction History

Kennedy Capital Management, Inc.

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$4.2 - $6.01 $999 - $1,430	238 Added 0.13%	176,809 $742,000
Q4 2022 Feb 14, 2023	SELL	$4.45 - $6.17 $600 - $832	-135 Reduced 0.08%	176,571 $1.06 Million
Q3 2022 Nov 14, 2022	SELL	$5.36 - $7.43 $1.74 Million - $2.41 Million	-323,728 Reduced 64.69%	176,706 $1.03 Million
Q2 2022 Aug 10, 2022	SELL	$3.55 - $6.27 $471,528 - $832,812	-132,825 Reduced 20.97%	500,434 $2.99 Million
Q1 2022 May 16, 2022	SELL	$1.9 - $5.23 $180,758 - $497,561	-95,136 Reduced 13.06%	633,259 $2.96 Million
Q4 2021 Feb 14, 2022	BUY	$1.44 - $2.86 $322,578 - $640,677	224,013 Added 44.41%	728,395 $1.81 Million
Q3 2021 Nov 15, 2021	BUY	$2.25 - $3.18 $1.13 Million - $1.6 Million	504,382 New	504,382 $1.49 Million
Q4 2020 Feb 12, 2021	SELL	$2.48 - $3.8 $24,800 - $38,000	-10,000 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$1.02 - $2.15 $10,200 - $21,500	10,000 New	10,000 $22,000
Q3 2018 Nov 14, 2018	SELL	$1.72 - $5.24 $678,548 - $2.07 Million	-394,505 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$3.81 - $5.26 $27,138 - $37,466	-7,123 Reduced 1.77%	394,505 $1.97 Million
Q1 2018 May 14, 2018	BUY	$2.7 - $4.06 $419,685 - $631,082	155,439 Added 63.14%	401,628 $1.57 Million
Q4 2017 Feb 13, 2018	BUY	$2.47 - $3.34 $608,086 - $822,271	246,189	246,189 $660,000

Ticker CTIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 114,385,000
Market Cap $1.04B
Description
CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients w...

Get notified when there are updates to the investment portfolio of Kennedy Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Kennedy Capital Management, Inc. with notifications on news.